JD Health (06618) Reports Interim Results with Revenue Up 24.5% to RMB 35.29 Billion

Stock News
08/14

JD Health (06618) announced its interim results for the six months ended June 30, 2025, with the group achieving revenue of RMB 35.29 billion, representing a year-on-year increase of 24.5%. Non-IFRS profit for the period reached RMB 3.57 billion, up 35% year-on-year, while net profit attributable to shareholders totaled RMB 2.596 billion, an increase of 27.45% year-on-year. Basic earnings per share stood at RMB 0.82.

As a leading innovative healthcare services company, JD Health responded to public demand by accelerating the improvement of health product and service supply quality in the first half of 2025, actively promoting AI-driven service model innovation, and committed to providing users with high-quality, accessible, and convenient health consumption and service experiences.

During the reporting period, the group's revenue reached RMB 35.3 billion, up 24.5% year-on-year. As of June 30, 2025, annual active users over the past 12 months exceeded 200 million, with daily consultation orders surpassing 500,000 in the first half of the year.

Revenue increased 23.7% from RMB 15.1 billion for the three months ended June 30, 2024, to RMB 18.6 billion for the three months ended June 30, 2025. The growth in total revenue was primarily driven by product revenue from the sale of pharmaceutical and health products, which increased 22.7% from RMB 23.9 billion for the six months ended June 30, 2024, to RMB 29.3 billion for the six months ended June 30, 2025.

The growth in product revenue was mainly driven by an increase in active users and additional purchases by users, the continuously improving online penetration rate of pharmaceutical and health product sales, and the enrichment of product categories.

Service revenue from online platforms, digital marketing, and other services increased 34.4% from RMB 4.4 billion for the six months ended June 30, 2024, to RMB 6.0 billion for the six months ended June 30, 2025. The growth in service revenue was primarily due to increased digital marketing service fees, mainly attributable to the growing number of advertisers on the platform, consistent with the continued growth in transactions on the platform.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10